HA
CLBT icon

Huntleigh Advisors’s Cellebrite CLBT Stock Holding History

Huntleigh Advisors’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-53,938
Closed -$973K – 290
2025
Q4 		$973K Buy
53,938
+2,909
+6% +$52.2K 0.16% 125
2025
Q3 		$946K Buy
51,029
+2,079
+4% +$32.7K 0.16% 124
2025
Q2 		$783K Buy
48,950
+1,821
+4% +$32.5K 0.15% 119
2025
Q1 		$916K Buy
47,129
+4,283
+10% +$90.1K 0.15% 102
2024
Q4 		$944K Buy
+42,846
New +$825K 0.2% 92

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Huntleigh Advisors's CLBT Position: Q1 2026 in Review

Huntleigh Advisors sold out of Cellebrite (CLBT) in Q1 2026, closing a stake of 53,938 shares — an estimated $973K sold.

Huntleigh Advisors first reported a position in CLBT in Q4 2024 and held it in 5 quarters. The position peaked at $973K in Q4 2025. 221 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • Huntleigh Advisors reported no remaining Cellebrite position as of Q1 2026 after selling out during the quarter.
  • Huntleigh Advisors sold 53,938 Cellebrite shares in Q1 2026, an estimated $973K.
  • Huntleigh Advisors first reported a position in Cellebrite in Q4 2024 and held it in 5 quarters.
  • Huntleigh Advisors's Cellebrite position peaked at $973K in Q4 2025.
  • 221 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Huntleigh Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.